Valvular heart disease in women registry
Part of Heart & circulation clinical trials.
This study is a registry that collects data on women with valvular heart disease (heart valve problems). It aims to better understand how these conditions affect women and improve their care. You may join if you have a heart valve condition and are treated at a participating center.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a heart valve problem as defined by current guidelines.
- You are being treated at a hospital or clinic taking part in this registry.
- You are able to give your consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects real-world information from people who have had—or plan to have—an eligible Medtronic cardiac surgery device. It aims to better understand how these treatments do over time and help guide future care.
This study enrolls adults in the hospital with certain heart valve problems to track their health over time. It may help doctors better understand how valve disease behaves and what outcomes look like in real life.
This study is a registry that collects information about people with severe heart valve problems who are planning to have a valve procedure. It may help doctors better understand your condition and treatment over time.
This study looks at people with moderate to severe heart valve disease (aortic, mitral, or tricuspid) who had at least two echocardiograms. It aims to learn more about how these conditions are managed in everyday medical practice.
This trial uses advanced CT scans to study people with moderate or severe heart valve disease. It aims to better understand valve problems and may help guide future treatments.
This study looks at people who have two or more heart valve problems that are moderate to severe. It aims to learn more about this condition and how to best manage it.
Hear when a new Guideline Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.